Raymond James & Associates Quidel Ortho Corp Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Quidel Ortho Corp stock. As of the latest transaction made, Raymond James & Associates holds 25,875 shares of QDEL stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,875

Previous 6,051 327.62%

Holding current value

$1.04 Million

Previous $201,000 486.57%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$29.96 - $46.4 $593,927 - $919,833	19,824 Added 327.62%	25,875 $1.18 Million
Q2 2024 Jul 19, 2024	SELL	$32.9 - $47.0 $291,099 - $415,856	-8,848 Reduced 59.39%	6,051 $201,000
Q1 2024 Apr 22, 2024	SELL	$41.76 - $74.73 $1.01 Million - $1.81 Million	-24,260 Reduced 61.95%	14,899 $714,000
Q4 2023 Jan 16, 2024	SELL	$58.16 - $75.44 $415,320 - $538,717	-7,141 Reduced 15.42%	39,159 $2.89 Million
Q3 2023 Oct 24, 2023	BUY	$70.9 - $88.63 $1.03 Million - $1.29 Million	14,537 Added 45.77%	46,300 $3.38 Million
Q2 2023 Jul 25, 2023	SELL	$81.09 - $94.16 $136,069 - $158,000	-1,678 Reduced 5.02%	31,763 $2.63 Million
Q1 2023 Apr 14, 2023	BUY	$82.98 - $91.46 $354,324 - $390,534	4,270 Added 14.64%	33,441 $2.98 Million
Q4 2022 Feb 08, 2023	BUY	$66.93 - $97.5 $388,863 - $566,475	5,810 Added 24.87%	29,171 $2.5 Million
Q3 2022 Oct 25, 2022	BUY	$69.86 - $107.63 $576,135 - $887,624	8,247 Added 54.57%	23,361 $1.67 Million
Q2 2022 Aug 12, 2022	BUY	$89.06 - $117.64 $1.35 Million - $1.78 Million	15,114 New	15,114 $1.47 Million

Others Institutions Holding QDEL

# of Institutions

293

Shares Held

67.9M

Call Options Held

337K

Put Options Held

134K

View Full List

About QuidelOrtho Corp

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.69B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

More about QDEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Quidel Ortho Corp Transaction History